Physician profile
Richard A Dellinger
NPI 1407814940
$1,713.36
in general payments reported to CMS, 2019-2025
22 companies · $63.36 in 2025
The $63.36 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $325 · 2020: $162 · 2021: $330 · 2022: $394 · 2023: $285 · 2024: $154 · 2025: $63.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $502.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $502.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $540.73 | 2019-2023 | Krystexxa |
| Nevro Corp. | $350.40 | 2021-2024 | Senza |
| Paratek Pharmaceuticals, INC. | $155.94 | 2022-2023 | Nuzyra |
| Paragon 28, INC. | $145.97 | 2021 | |
| Smith+Nephew, INC. | $73.61 | 2019-2022 | |
| Amgen INC. | $63.36 | 2025 | Krystexxa |
| Progenacare Global, LLC | $47.89 | 2023 | |
| Averitas Pharma INC. | $42.70 | 2024 | Qutenza |
| Baudax Bio INC. | $41.17 | 2021 | |
| Stimwave Technologies Incorporated | $34.79 | 2021-2022 | |
| Inari Medical, INC. | $34.35 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Polynovo North America LLC | $33.83 | 2023 | |
| Treace Medical Concepts, INC. | $27.50 | 2022 | |
| Misonix INC | $23.73 | 2019 | |
| Integra Lifesciences Corporation | $17.36 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zyla Life Sciences, INC. | $15.92 | 2019 | |
| Organogenesis INC. | $14.85 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $14.77 | 2023 | Seglentis |
| Dynasplint Systems INC. | $12.65 | 2019 | |
| Merck Sharp & Dohme LLC | $12.58 | 2019 | |
| Amniox Medical, INC. | $9.26 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Dellinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.